JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.13, no.2, pp.284-290, 2017 (SCI-Expanded)
Background: The national protocol aimed to improve the outcome of the high risk neuroblastoma patients by high-dose chemotherapy and stem cell rescue with intensive multimodal therapy.